Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Study Details
Study Description
Brief Summary
Surgical reconstruction to restore oral function and aesthetics after major ablative surgery in the oral cavity forms a challenge to maxillofacial surgeons, and greatly impacts patient' quality of life (QOL). The "Oncological-bridge (O-bridge®)" protocol, which offers (immediate/delayed) fixed prosthetic rehabilitation in a minimum of sessions and a strongly reduced two-week treatment time.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
Surgical reconstruction to restore oral function and aesthetics after major ablative surgery in the oral cavity forms a challenge to maxillofacial surgeons, and greatly impacts patient' quality of life (QOL). The "Oncological-bridge (O-bridge®)" protocol, which offers (immediate/delayed) fixed prosthetic rehabilitation in a minimum of sessions and a strongly reduced two-week treatment time.
Objective: The investigators aim to demonstrate the added value of the "O-bridge® protocol" in a larger sample size of at least 20 patients eligible for (immediate/delayed) fixed prosthodontic rehabilitation at time of oral cavity (mandibular) reconstruction study design: a prospective, observational cohort study. The "O-bridge® protocol", in which the standardized concept of implant loading and that of oral cavity (mandibular) reconstruction are combined with an adapted prosthetic manufacturing protocol, will be offered to eligible patients requiring ablative surgery because of a benign or malignant tumour of the oral cavity or stage 3-4 osteonecrosis.
All patients will be screened by the local maxillofacial surgeon and the prosthodontist to determine eligibility for the procedure. Imaging will be performed as part of routine surgical preparation. Clinical function, as measured with the 11-item scale by Rogers and intelligibility of speech will be assessed by the speech therapist and/or appointed health care employee prior to surgery, 3 months post-surgery and/or at time of implant placement, and at 6 weeks after placement of the O-bridge®. In addition, EORTC quality of life C30 and HN35 questionnaires will also be completed at those time-points, and at 6 months after placement of the O-bridge®. Speech-, food- and prosthetic fit-related items from the Oral Health Impact Profile (OHIP) questionnaire will be completed at 6 weeks and at 6 months after placement of the O-bridge®. Parameters related to implant and bridge stability and patient satisfaction, measured through a 10-point visual analogue scale, will be assessed at 6, 12, 24, 36, 48 and 60 months at routine follow-up consultation after placement of the O-bridge®.
As a primary endpoint, the investigators aim to demonstrate that the O-bridge® protocol significantly improves short-term patient' quality of life.
Moreover, the investigators aim to demonstrate the validity and reliability of the O-bridge® protocol, based on its short- and long-term biologic implant stability and mechanical stability of the prosthesis. In addition, they aim to measure the impact of the O-bridge® on speech intelligibility.
Study Design
Outcome Measures
Primary Outcome Measures
- EORTC QLQ C30, for measurement of quality of life [6 weeks after O-bridge placement]
short-term quality of life after dental restoration with the O-bridge, measured through the EORTC QLQ C30 questionnaire
- EORTC QLQ H&N35, for measurement of quality of life [6 weeks after O-bridge placement]
short-term quality of life after dental restoration with the O-bridge, measured through the EORTC QLQ HN35 questionnaire
- EORTC QLQ C30, for measurement of quality of life [6 months after O-bridge placement]
short-term quality of life after dental restoration with the O-bridge, measured through the EORTC QLQ C30
- EORTC QLQ H&N35, for measurement of quality of life [6 months after O-bridge placement]
short-term quality of life after dental restoration with the O-bridge, measured through the EORTC QLQ HN35
- OHIP, for measurement of quality of life [6 weeks after O-bridge placement]
short-term quality of life after dental restoration with the O-bridge, measured through the OHIP questionnaire
- OHIP, for measurement of quality of life [6 months after O-bridge placement]
short-term quality of life after dental restoration with the O-bridge, measured through the OHIP questionnaire
Secondary Outcome Measures
- percentage of patients with marginal bone loss around implants [until one year post implantation]
short-term biologic implant stability, measured through OPG imaging
- percentage of patients with marginal bone loss around implants [until five years post implantation]
long-term biologic implant stability, measured through OPG imaging
- percentage of patients with mechanical stability problems of the prosthesis [until one year post implantation]
short-term, measured through clinical evaluation
- percentage of patients with mechanical stability problems of the prosthesis [until five years post implantation]
long-term, measured through clinical evaluation
- percentage of patients with difficulties in speech intelligibility [prior to and 6 weeks post O-bridge]
impact of the O-bridge on speech intelligiblity, measured through reading of a predefined oronasal text interpreted by the speech and language pathologist
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with a histologically or clinically confirmed diagnosis of ORN, MRONJ, as classified by respectively Lyons et al. (Lyons, et al., 2014) and Ruggiero et al. (Ruggiero, et al., 2009) (Ruggiero, et al., 2014) or a benign or malignant tumour located in the oral cavity and jaw bone (NCCN, 2015) (Sobin, et al., 2009), requiring marginal, segmental or total jaw resection
-
Patients eligible for jaw and oral cavity reconstruction combined with immediate/delayed implant loading for fixed prosthetic rehabilitation
-
Patients not eligible for conventional removable prosthetic rehabilitation
Exclusion Criteria:
-
Patients not eligible to the abovementioned criteria
-
Patients with a clinically confirmed diagnosis of osteonecrosis not related to an oncological diagnosis or treatment
-
Patients with medical contraindications for jaw reconstruction combined with immediate implant loading for fixed prosthetic rehabilitation
-
Patients whose maternal language is non-Dutch or non-English will be excluded from the acoustic speech evaluation. A perceptual evaluation of speech intelligibility can still be performed.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ziekenhuis Netwerk Antwerpen | Antwerp | Belgium | ||
| 2 | ZMACK association - Antwerp University Hospital | Antwerp | Belgium | ||
| 3 | Division of Oral and Maxillofacial Surgery, Department of Surgery, AZ Sint-Jan Brugge-Oostende AV | Bruges | Belgium | ||
| 4 | University Hospital Leuven | Leuven | Belgium | ||
| 5 | AZ Nikolaas | Sint-Niklaas | Belgium |
Sponsors and Collaborators
- AZ Sint-Jan AV
Investigators
- Principal Investigator: Johan Abeloos, MD, AZ Sint-Jan Brugge-Oostende AV
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- B322201731284